Euglena Co., Ltd. (TYO:2931)

Market Cap	56.68B
Revenue (ttm)	49.43B
Net Income (ttm)	18.00M
Shares Out	136.58M
EPS (ttm)	0.13
PE Ratio	3,148.89
Forward PE	126.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	687,100
Average Volume	911,670
Open	411.00
Previous Close	410.00
Day's Range	408.00 - 416.00
52-Week Range	394.00 - 541.00
Beta	-0.10
RSI	55.43
Earnings Date	Feb 13, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, and midori koji; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorpor...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 897
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2024, Euglena's revenue was 47.62 billion, an increase of 2.44% compared to the previous year's 46.48 billion. Losses were -650.00 million, -75.49% less than in 2023.